Making Best Practice, Every Day Practice
The levonorgestrel-releasing intrauterine system (LNG-IUS; Mirena) was first licensed in the UK for contraception in 1995. But it soon became evident that it had other clinical advantages and the LNG-IUS is now also available for the prevention of endometrial hyperplasia in women who are taking oestrogen as part of hormone replacement therapy (HRT).
A 40-year-old woman with hot flushes, tearfulness and low libido could be going through early menopause. But there might be other explanations for her symptoms, and a careful history and investigation are essential to ensure that she receives the right treatment.
A unique new e-platform for primary care
By continuing to this site you are confirming that you are a healthcare professional and are opting into the use of cookies.
